EMPAFLO 10 MG COM REV CT BL AL PLAS PVC/PVDC OPC X 30

Presentation · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brazil

  • Registration number 1058310260024
  • GGREM 526126070188607
  • Barcode 7896004823348

What the source publishes

Holder
GERMED FARMACEUTICA LTDA
Active ingredients
EMPAGLIFLOZINA
Package
10 MG COM REV CT BL AL PLAS PVC/PVDC OPC X 30
Supply regime
Tarja Vermelha
Product type
Similar
Therapeutic class
A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS
Prescription
Prescription or restricted

Names this record is found by

Complete source data
br:cmed:presentations:526126070188607
{
  "name": "EMPAFLO 10 MG COM REV CT BL AL PLAS PVC/PVDC OPC X 30",
  "holder": "GERMED FARMACEUTICA LTDA",
  "stripe": "Tarja Vermelha",
  "barcodes": [
    "7896004823348"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "526126070188607",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "45.992.062/0001-65",
  "priceRegime": "Regulado",
  "productName": "EMPAFLO",
  "productType": "Similar",
  "hospitalOnly": false,
  "presentation": "10 MG COM REV CT BL AL PLAS PVC/PVDC OPC X 30",
  "sourceStatus": null,
  "supplyRegime": "Tarja Vermelha",
  "factoryPrices": {
    "icms-0": "87.36",
    "icms-12": "99.27",
    "icms-17": "105.25",
    "icms-18": "106.54",
    "icms-19": "107.85",
    "icms-20": "109.20",
    "icms-21": "110.58",
    "icms-22": "112.00",
    "icms-23": "113.45",
    "icms-17.5": "105.89",
    "icms-19.5": "108.52",
    "icms-20.5": "109.89",
    "icms-22.5": "112.72",
    "icms-12-alc": "88.64",
    "icms-17-alc": "93.98",
    "icms-18-alc": "95.12",
    "icms-19-alc": "96.30",
    "icms-20-alc": "97.50",
    "icms-21-alc": "98.73",
    "icms-22-alc": "100.00",
    "icms-23-alc": "101.30",
    "withoutTaxes": "78.00",
    "icms-17.5-alc": "94.55",
    "icms-19.5-alc": "96.89",
    "icms-20.5-alc": "98.11",
    "icms-22.5-alc": "100.65"
  },
  "pisCofinsList": "Negativa",
  "substanceText": "EMPAGLIFLOZINA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "117.19",
    "icms-12": "133.17",
    "icms-17": "141.19",
    "icms-18": "142.92",
    "icms-19": "144.68",
    "icms-20": "146.49",
    "icms-21": "148.34",
    "icms-22": "150.24",
    "icms-23": "152.19",
    "icms-17.5": "142.05",
    "icms-19.5": "145.58",
    "icms-20.5": "147.41",
    "icms-22.5": "151.21",
    "icms-12-alc": "122.54",
    "icms-17-alc": "129.92",
    "icms-18-alc": "131.50",
    "icms-19-alc": "133.13",
    "icms-20-alc": "134.79",
    "icms-21-alc": "136.49",
    "icms-22-alc": "138.24",
    "icms-23-alc": "140.04",
    "withoutTaxes": "107.83",
    "icms-17.5-alc": "130.71",
    "icms-19.5-alc": "133.94",
    "icms-20.5-alc": "135.63",
    "icms-22.5-alc": "139.14"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "EMPAGLIFLOZINA"
  ],
  "therapeuticClass": "A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1058310260024",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "prescription-or-restricted",
  "prescriptionRequired": true,
  "therapeuticClassCode": "A10P1",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:526126070188607"